Logo of National Eczema Association mobile menu icon
Icon link to National Eczema's Instagram feed. Icon link to National Eczema's YouTube channel. Icon link to National Eczema's Facebook page. Icon link to National Eczema's Twitter feed. Icon link to National Eczema's inspire.com page. Search Icon to search the site

Get the tools and support you need to best manage your eczema

  • This field is for validation purposes and should be left unchanged.

Clinical Trial Details for Improving Value of Care for Patients With Severe Stasis Dermatitis


University Hospitals Cleveland Medical Center
NCT ID: NCT03022786
Last Updated: April 17, 2019

The Study at a Glance

  • Status: Recruiting
  • Phase: N/A
  • Gender: All
  • Age: 18 Years - 99 Years
  • Condition: Stasis Dermatitis
  • Study Type: Interventional
  • Intervention:
  • Lead Sponsor: University Hospitals Cleveland Medical Center
  • Location: Not Provided

Official Title

Improving Value of Care for Patients With Severe Stasis Dermatitis

Purpose

Explore the unmet needs of patients admitted to the hospital for severely inflamed skin of the lower legs, often described as 'bilateral cellulitis". These patients usually have intractable lower extremity edema, stasis dermatitis and sometimes allergic contact dermatitis rather than an infectious process; readmission is common. Investigators will create patient and provider education materials to align dermatological, home health, and other resources and measure reduction in hospital re-admission rate and length of stay.

Eligibility

Ages Eligible for Study

18 Years to 99 Years

Sexes Eligible for Study

All

Accepts Healthy Volunteers

No

Criteria

Inclusion Criteria:

– Over the age of 18

– Inpatient admission to the hospital for inflamed skin of the lower legs, bilateral
cellulitis, and contact dermatitis

– Fluent in English

Exclusion Criteria:

– Patients under the age of 18

– Illiterate patients

– Non-English speaking patients

– Outpatients

Additional Information, Locations & Contacts

Sponsors & Collaborators

University Hospitals Cleveland Medical Center

Pfizer

Ohio Dermatological Association

Investigators

Principal Investigator: Susan Nedorost, MD

University Hospitals Cleveland Medical Center

Please refer to this study by its ClinicalTrials.gov identifier: NCT03022786

Location

Contacts

University Hospitals

Cleveland, Ohio 44106

United States